(Circulation. 1997;96:15-18.)
© 1997 American Heart Association, Inc.
Articles |
Thrombomodulin Gene Mutations Associated With Myocardial Infarction
From the Department of Haematology (H.I., G.K., K.K., D.A.L.) and Academic Unit of Cardiovascular Medicine (P.J.S.), Charing Cross and Westminster Medical School, London, UK.
Correspondence to Helen Ireland, PhD, Haematology Department, Charing Cross and Westminster Medical School, St Dunstans Road, London W6 8RP, UK. E-mail h.ireland{at}cxwms.ac.uk
Background Thrombomodulin is an important receptor for thrombin on the endothelial cell surface of most blood vessels, including those of the heart. Thrombin-bound thrombomodulin activates protein C, which inhibits thrombin generation by degrading factors Va and VIIIa. The aim of this study was to analyze the 5' region of the thrombomodulin gene to determine whether mutations contribute a risk for myocardial infarction.
Methods and Results We screened the promoter region of the thrombomodulin gene by single-stranded conformation polymorphism analysis in 104 patients with diagnosed myocardial infarction. Five mutations (three distinct) were identified (GG-9/-10AT, G-33A, and C-133A). The dinucleotide mutation GG-9/-10AT was identified in 3 individuals (2 heterozygous, 1 homozygous). Only one of the three different mutations was identified in 104 patient control subjects matched for age, sex, and race (G-33A in a single individual). All mutations identified were in close proximity to consensus sequences for transcription control elements within the thrombomodulin gene. In contrast, no difference was observed between patients and control subjects for the allelic frequency of a previously identified neutral polymorphism GCC/GTC coding for Ala/Val455, with 3 individuals homozygous for GTC (Val) in both groups.
Conclusions The findings suggest that mutations in the promoter region of the thrombomodulin gene may constitute a risk for arterial thrombosis.
Key Words: myocardial infarction • endothelium • thrombosis • genetics
This article has been cited by other articles:
 |
|
 |
|
  K. Auro, K. Komulainen, M. Alanne, K. Silander, L. Peltonen, M. Perola, and V. Salomaa Thrombomodulin Gene Polymorphisms and Haplotypes and the Risk of Cardiovascular Events: A Prospective Follow-Up Study Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 942 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Gibbons, C. C. Liew, M. O. Goodarzi, J. I. Rotter, W. A. Hsueh, H. M. Siragy, R. Pratt, and V. J. Dzau Genetic Markers: Progress and Potential for Cardiovascular Disease Circulation, June 29, 2004; 109(25_suppl_1): IV-47 - IV-58. [Full Text] [PDF]
|
|
|
|
|
|
M. Levi, T. van der Poll, and H. R. Buller Bidirectional Relation Between Inflammation and Coagulation Circulation, June 8, 2004; 109(22): 2698 - 2704. [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Conway, M. Van de Wouwer, S. Pollefeyt, K. Jurk, H. Van Aken, A. De Vriese, J. I. Weitz, H. Weiler, P. W. Hellings, P. Schaeffer, et al. The Lectin-like Domain of Thrombomodulin Confers Protection from Neutrophil-mediated Tissue Damage by Suppressing Adhesion Molecule Expression via Nuclear Factor {kappa}B and Mitogen-activated Protein Kinase Pathways J. Exp. Med., September 2, 2002; 196(5): 565 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kunz, A.-K. Ohlin, A. Adami, B. Zoller, P. Svensson, and D. A. Lane Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function Blood, May 15, 2002; 99(10): 3646 - 3653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Weiler, V. Lindner, B. Kerlin, B. H. Isermann, S. B. Hendrickson, B. C. Cooley, D. A. Meh, M. W. Mosesson, N. W. Shworak, M. J. Post, et al. Characterization of a Mouse Model for Thrombomodulin Deficiency Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1531 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. G. Laszik, X. J. Zhou, G. L. Ferrell, F. G. Silva, and C. T. Esmon Down-Regulation of Endothelial Expression of Endothelial Cell Protein C Receptor and Thrombomodulin in Coronary Atherosclerosis Am. J. Pathol., September 1, 2001; 159(3): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF]
|
|
|
|
 |
|
 M. S. Williams and P. F. Bray Genetics of Arterial Prothrombotic Risk States Experimental Biology and Medicine, May 1, 2001; 226(5): 409 - 419. [Abstract] [Full Text]
|
|
|
|
|
|
K. K. Wu, N. Aleksic, C. Ahn, E. Boerwinkle, A. R. Folsom, and H. Juneja Thrombomodulin Ala455Val Polymorphism and Risk of Coronary Heart Disease Circulation, March 13, 2001; 103(10): 1386 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Le Flem, L. Mennen, M.-L. Aubry, M. Aiach, P.-Y. Scarabin, J. Emmerich, and M. Alhenc-Gelas Thrombomodulin Promoter Mutations, Venous Thrombosis, and Varicose Veins Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 445 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T C F Sykes, C Fegan, and D Mosquera Thrombophilia, polymorphisms, and vascular disease Mol. Pathol., December 1, 2000; 53(6): 300 - 306. [Abstract] [Full Text]
|
|
|
|
|
|
D. A. Lane and P. J. Grant Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease Blood, March 1, 2000; 95(5): 1517 - 1532. [Full Text] [PDF]
|
|
|
|
|
|
G. Kunz, H. A. Ireland, P. J. Stubbs, M. Kahan, G. C. Coulton, and D. A. Lane Identification and characterization of a thrombomodulin gene mutation coding for an elongated protein with reduced expression in a kindred with myocardial infarction Blood, January 15, 2000; 95(2): 569 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Gunn and D Cumberland Stent coatings and local drug delivery. State of the art Eur. Heart J., December 1, 1999; 20(23): 1693 - 1700. [PDF]
|
|
|
|
|
|
R. E. Simmonds and D. A. Lane Structural and Functional Implications of the Intron/Exon Organization of the Human Endothelial Cell Protein C/Activated Protein C Receptor (EPCR) Gene: Comparison With the Structure of CD1/Major Histocompatibility Complex alpha 1 and alpha 2 Domains Blood, July 15, 1999; 94(2): 632 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Keightley, Y. M. Lam, J. N. Brady, C. L. Cameron, and D. Lillicrap Variation at the von Willebrand Factor (vWF) Gene Locus Is Associated With Plasma vWF:Ag Levels: Identification of Three Novel Single Nucleotide Polymorphisms in the vWF Gene Promoter Blood, June 15, 1999; 93(12): 4277 - 4283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Le Flem, V. Picard, J. Emmerich, S. Gandrille, J.-N. Fiessinger, M. Aiach, and M. Alhenc-Gelas Mutations in Promoter Region of Thrombomodulin and Venous Thromboembolic Disease Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 1098 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gosling, J. Golledge, R. J. Turner, and J. T. Powell Arterial Flow Conditions Downregulate Thrombomodulin on Saphenous Vein Endothelium Circulation, March 2, 1999; 99(8): 1047 - 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gonzalez-Conejero, M. L. Lozano, J. Rivera, J. Corral, J. A. Iniesta, J. M. Moraleda, and V. Vicente Polymorphisms of Platelet Membrane Glycoprotein Ibalpha Associated With Arterial Thrombotic Disease Blood, October 15, 1998; 92(8): 2771 - 2776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M A LAFFAN Activated protein C resistance and myocardial infarction Heart, October 1, 1998; 80(4): 319 - 321. [Full Text]
|
|
|
|
|
|
D A Gorog, R Rakhit, D Parums, M Laffan, and G J Davies Raised factor VIII is associated with coronary thrombotic events Heart, October 1, 1998; 80(4): 415 - 417. [Abstract] [Full Text]
|
|
|
|
|
|
R. De Cristofaro, E. De Candia, and R. Landolfi Effect of High- and Low-Molecular-Weight Heparins on Thrombin-Thrombomodulin Interaction and Protein C Activation Circulation, September 29, 1998; 98(13): 1297 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Laffan Genetics and pulmonary medicine bullet 4: Pulmonary embolism Thorax, August 1, 1998; 53(8): 698 - 702. [Full Text]
|
|
|
|
 |
|
 J.-M. Olivot, E. Estebanell, M. Lafay, B. Brohard, M. Aiach, and F. Rendu Thrombomodulin Prolongs Thrombin-Induced Extracellular Signal-Regulated Kinase Phosphorylation and Nuclear Retention in Endothelial Cells Circ. Res., April 13, 2001; 88(7): 681 - 687. [Abstract] [Full Text] [PDF]
|
|